Drug Use Investigation for HEPSERA (Adefovir) Tablet
NCT01863589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 436
Last updated 2013-05-29
Summary
This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir tablets.
Conditions
Interventions
- DRUG
-
Adefovir tablets
Administered according to the prescribing information in the locally approved label by the authorities.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Primary Completion
- 2007-06-30
- Completion
- 2012-07-31
More Related Trials
-
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
NCT00065507 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B
NCT00116805 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
NCT00496158 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed
NCT02979613 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
NCT02258581 ·Status: TERMINATED
-
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine
NCT00640588 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
NCT00496002 ·Status: TERMINATED ·Phase: PHASE3
-
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
NCT00641082 ·Status: COMPLETED ·Phase: PHASE4
-
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients
NCT01356901 ·Status: COMPLETED
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
NCT07307586 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)
NCT03180619 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
NCT02965859 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
NCT05905458 ·Status: COMPLETED ·Phase: PHASE2
-
Lamivudine and Adefovir Dipivoxil Fixed Dose Combination
NCT01353742 ·Status: COMPLETED ·Phase: PHASE1
-
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
NCT01379508 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
NCT00230503 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
NCT01205165 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients
NCT01958229 ·Status: COMPLETED
-
Lamivudine and Adefovir to Treat Chronic Hepatitis B
NCT00023309 ·Status: COMPLETED ·Phase: PHASE2
-
Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
NCT00013702 ·Status: COMPLETED ·Phase: PHASE2
-
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
NCT01581554 ·Status: COMPLETED
-
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
NCT00307489 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated
NCT02579382 ·Status: COMPLETED ·Phase: PHASE2
-
Suboptimal Responders to Adefovir Switching to Entecavir
NCT00718887 ·Status: COMPLETED ·Phase: PHASE4